Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Siegburg

7 clinical trials in Siegburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Siegburg at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Siegburg

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Universitaetsklinikum Heidelberg AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Heidelberg AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Heidelberg AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Technische Universitaet Dresden
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:University Of Cologne

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Siegburg

What the registry says about research in the country

01 Hematologic Oncology

Groundbreaking research focusing on chronic lymphocytic leukemia (CLL) and related conditions, evaluating innovative treatment combinations to improve patient outcomes.

  • Fixed-duration therapies vs. MRD-guided approaches
  • Novel drug combinations for untreated CLL
  • High-risk CLL patient treatments

Studies are investigating the effectiveness of various therapeutic combinations including venetoclax, obinutuzumab, and pirtobrutinib.

02 Multiple Myeloma Research

Advanced clinical investigations in multiple myeloma treatment, exploring maintenance therapy options and drug administration methods.

  • Post-transplant maintenance therapy
  • Intravenous vs. subcutaneous administration
  • Novel drug combinations

Research focuses on improving treatment delivery methods and evaluating maintenance strategies after stem cell transplantation.

03 Gastrointestinal Oncology

Innovative research in colon cancer treatment strategies, particularly focusing on stage II disease management.

  • Circulating tumor DNA analysis
  • Adjuvant therapy optimization
  • Disease-free survival assessment

Studies are evaluating personalized treatment approaches based on molecular markers for better patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.